Study shows promise for new drug to treat Fragile X

The first drug to treat the underlying disorder instead of the symptoms of Fragile X, the most common cause of inherited intellectual disability, shows some promise according to a new study published in the January 5 issue of Science Translational M…

Treating fractures: Children are not miniature adults

Treating fractures in children requires special knowledge of growth physiology. Incorrect treatment of bone fractures in child and adolescent patients is less often caused by technical deficiencies than by a misjudgment of the special conditions in …

Care of late-preterm preemies may be insufficient

MAYWOOD, Ill. — In the last 15 years the U.S has seen a sharp increase in the number of babies born as late-preterm infants, between 34 and 37 weeks’ gestation. This is approximately 400,000 children each year, comprising over 70 percent of all pr…

International clinical trial tests targeted drug for melanoma

CHICAGO — Rush University Medical Center has just enrolled the first U.S. patient in an international clinical trial testing a novel drug to treat certain kinds of melanoma, a deadly skin cancer that in its advanced stages currently has few effect…

Get more stuff like this
in your inbox

From anti-aging to the search for alien life, we promise to never bore.